We are pleased to share that we will attend MEET2WIN 2025, a unique European partnering event entirely dedicated to open innovation in oncology.
Our multidisciplinary team can guide you through every stage of your product lifecycle, from clinical development and real-world evidence to transaction advisory. Take this opportunity to connect with our delegates and discover how we can help you accelerate innovation and deliver tomorrow’s standard of care for oncology patients.
Nuclear medicine is entering a game-changing era. Breakthroughs in radiopharmaceuticals, cutting-edge clinical advancements, and surging investments are propelling the field forward.
Our pharma clients sought support to evaluate and leverage the data generated from US trial in other markets and develop a mitigation plan for gaps in evidence.